MitchellGoldmanMD

PubMed

• 2 citations
  Thrombocytopenia and disseminated histoplasmosis in immunocompetent adults.
  Issa Kutkut, Laura B. Vater, Mitchell Goldman, Magdalena Czader, Jessica Swenberg, Zachary Fulkerson, Rakesh Mehta> ;Clinical Case Reports. 2017 Oct 18
• 37 citations
  Dolutegravir: A Next-Generation Integrase Inhibitor for Treatment of HIV Infection
  Danielle Osterholzer, Mitchell Goldman> ;Clinical Infectious Diseases. 2014 Apr 9
• 41 citations
  A Randomized Study of the Use of Fluconazole in Continuous versus Episodic Therapy in Patients with Advanced HIV Infection and a History of Oropharyngeal Candidiasis: ...
  Mitchell Goldman, Gretchen A. Cloud, Karen D. Wade, Annette C. Reboli, Carl J. Fichtenbaum, Richard Hafner, Jack D. Sobel, William G. Powderly, Thomas F. Patterson, La...> ;Clinical Infectious Diseases. 2005 Nov 15
• 81 citations
  Safety of Discontinuation of Maintenance Therapy for Disseminated Histoplasmosis after Immunologic Response to Antiretroviral Therapy
  Mitchell Goldman, Robert Zackin, Carl J. Fichtenbaum, Daniel J. Skiest, Susan L. Koletar, Richard Hafner, L. Joseph Wheat, Peter M. Nyangweso, Constantin T. Yiannoutso...> ;Clinical Infectious Diseases. 2004 May 15
• 38 citations
  Fungal pneumonias: The endemic mycoses
  Mitchell Goldman, Philip C. Johnson, George A. Sarosi> ;Clinics in Chest Medicine. 1999 Sep 1
• Join now to see all

Journal Articles

• Dolutegravir: a next generation integrase inhibitor for treatment of HIV infection  
  *Oserholzer D, Goldman M, Clin Infect Dis, 1/15/2014
• Safety, Immunogenicity and Surrogate Markers of Clinical Efficacy for Modified Vaccinia Ankara as a Smallpox Vaccine in HIV Infected Subjects  
  *Greenberg RN, Overton ET, HaasDW,Frank I, Goldman M, von Krempelhuber A, Virgin G ,Baedecker N,Vollmar J, and Chaplin P, J Infect Dis, 1/1/2013
• Worsening Endothelial Function with Efavirenz Compared to Protease Inhibitors: A 12-Month Prospective Study  
  *Gupta SK, Shen C, Moe SM, Kamendulis LM, Goldman M, et al., PLoS ONE, 1/1/2012
• A 61 year old immunosuppressed man with a symptomatic pulmonary infiltrate  
  Luraschi-Monjagatta C, Noon A, Ampel N, Chavez S, Goldman M, Knox KS, Southwest J Pulm Crit Care, 1/1/2011
• Histoplasma antigen clearance during treatment of histoplasmosis in patients with AIDS in a quantitative antigen enzyme  
  *Hage CA , Hackett EJ, Stump TE, Kauffman CA, Goldman M, Connolly P, Johnson PC, Wheat LJ , Baddley JW, Clinical & Vaccine Immunology, 1/1/2011
• Renal function and clinical outcomes in HIV-Infected Kenyans not initially requiring antiretroviral therapy  
  *Gupta SK, OwinoOng’orW, Shen C, Wafula S, Musick B, Goldman M, Wools-Kaloustian K., Journal of the Interntational AIDS Society, 1/1/2011
• Idiopathic granulomatous mastitis cases in hispanic women – Indiana, 2006-2008 Reprinted from Morbidity and Mortality Weekly Report  
  *Goldman M,Selke HM, Pardo I, Clare SE, Emerson RE, Howell JF, Shieh W-J, Zaki S, Sanchez C, Sinkowitz-Cochran RL, Srinivasan A , Jhung M, Ritchey M, Jarquin VG, Meite..., JAMA, 1/1/2010
• Reconstitution of CD4 T cells in BAL after initiation of highly active antiretroviral therapy  
  *Knox KS, Vinton C, Hage CA, Kohli LM, Twigg III HL, Zwickl B, Waltz J, GoldmanM, Douek DC, Brenchley JM, Journal of Virology, 1/1/2010
• Salvage treatment of histoplasmosis with posaconazole  
  *Restrepo A, Tobón, A, Clark B, Graham DR, Corcoran G, Bradsher RW, Goldman M, PankeyG, Moore T, Negroni R, Graybill JR, Journal of Infection, 1/1/2007
• Survival after disseminated invasive aspergillosis in a multivisceral transplant recipient  
  *Vianna R, Misra V, Fridell JA. Goldman M. Mangus RS, Tector J, Transplantation Proceedings, 1/1/2007
• Renal disease in an antiretroviral naïve HIV-infected outpatient population in Western Kenya  
  *Wools-Kaloustian K, Muloma E, Gupta SK, Owino-Ong’Or W, Sidle J, Aubrey RW, Shen J, Kipruto K, Zwickl BE, Goldman M, Nephrology Dialysis Transplantation, 1/1/2007
• Long-term efficacy and safety of Tipranavir boosted ritonavir in HIV-1 infected patients failing multiple protease inhibitor regimens:80 week data from a phase 2 study  
  *Markowitz M, Slater LN, Schwartz R, Kazanjian PH, Hathaway B, Wheeler D, Goldman, M, Neubacher D, Mayers D, Valdez H, McCallister S and the BI 1182.2 Study Team, J Acquir Immune Defic Syndr, 1/1/2007
• Activity of newer triazoles against Histoplasmacapsulatum from patients with AIDS who failed fluconazole  
  *Wheat LJ, ConnollyP, Smedema M, Durkin M, Brizendine E, Mann P, Patel R, McNicholass PM, Goldman M, Journal of Antimicrobial Chemotherapy, 1/1/2006
• Clinical research in the lay press: irresponsible journalism raises a huge dose of doubt  
  *Anaissie EJ, Segal BH, Graybill JR, Arndt C, Perfect JR, Kleinberg M, Pappas P, Benjamin D, Rubin R, Aberg JA,Adderson EE, Adler-Shohet FC, Akan H, Akova M, Almyr..., Clinical Infectious Diseases, 1/1/2006
• Pharmacokinetics of intravenously adminsitered levofloxacin in men and women  
  *Overholser BR, Kays MB, Lagvankar S, Goldman, M, Mueller, BA, Sowinski KM, Pharmacotherapy, 1/1/2005
• A randomized study of the use of fluconazole as continuous versus episodic therapy in patients with advanced HIV infection and history of oropharyngeal candidiasis AI...  
  *Goldman M, Cloud GA, Wade KD, Reboli A, Fichtenbaum CJ, Hafner R, Sobel JD, Powderly WG, Patterson TF, Wheat LJ, Stein DK, Dismukes WE, Filler SG, Clin Infect Dis, 1/1/2005
• Effect of ensure on the oral bioavailability of gatifloxacin in healthy volunteers  
  *Kays MB, Overholser BR, Lagvankar S, Goldman M,Sowinski KM, Pharmacotherapy, 1/1/2005
• Safety of discontinuation of maintenance therapy for disseminated histoplasmosis following immunologic response to antiretroviral therapy AIDS Clinical Trials Group St...  
  *Goldman M, Zackin R, Fichtenbaum CJ , Skiest DJ, Koletar Susan L, Hafner R, Wheat LJ, Nyangweso PM, Yiannoutsos CT, Schnizlein-Bick CT, Owens S, Aberg JA, and the AID..., Clinical Infectious Diseases, 1/1/2004
• Relapse of coccidiodomycosis despite immune reconstitution after fluconazole secondary prophylaxis in AIDS  
  *Mathew G, Smedima M, Wheat LJ, Goldman, M, Mycoses, 1/1/2003
• A multicenter randomized trial of intravenous/oral itraconazole versus intravenous/oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoetic ste...  
  *Winston DJ, Maziarz RT,.Chandrasekar PH,. Lazarus HM, Goldman M, Blumer JL, Leitz G, Territo MC, Annals of Internal Medicine, 1/1/2003
• A randomized and blinded multicenter trial of high-dose fluconazole plus placebo vs fluconazole plus amphotericin B as therapy of candidemia and its consequences in no...  
  *Rex JH, Pappas PG, Karchmer AW, Sobel J, Edwards JE, Hadley S, Brass C, Vazquez JA, Chapman SW, Horowitz H, Zervos M, Lee J, Babinchak T, Bradsher RW, Cohen DM, Danz..., Clinical Infectious Diseases, 1/1/2003
• Infectious disease prophylaxis in renal transplant patients: A survey of US transplant centers  
  Batiuk TD, Bodziak KA, *Goldman, M, Clinical Transplantation, 1/1/2002
• Predictive value of HIV-1 viral load on risk for opportunistic infections  
  *Swindells S, Evans S, Zackin R, Goldman M, Haubrich R, Filler SG, Balfour HH Jr., JAIDS, 1/1/2002
• Safety and efficacy of liposomal amphotericin B compared with conventional Amphotericin B for the induction therapy of histoplasmosis in patients with AIDS  
  *Johnson, PD, Wheat, LJ, Cloud GC, Goldman M, Lancaster D, Bamberger DM, Powderly WG, Hafner R, Kauffman CA, Dismukes WE and the NIAID Mycoses Study Group, Annals of Internal Medicine, 1/1/2002
• Incidence of histoplasmosis following allogeneic bone marrow transplant or solid organ transplant in a hyperendemic area  
  *Vail GM, Young RS, Wheat LJ, Filo RS, Cornetta K, Goldman M, Transpl Infect Dis, 1/1/2002
• Join now to see all

Books/Book Chapters

• "Pulmonary Infection in the Immunocompromised Patient: Strategies for Management” 
  Chapter: Current strategies in the treatment of fungal in the intensive care unit setting. 
  Page 349 - 382*Goldman M,Sarosi GAEditors: Agusti C, Torres A.John Wiley and Sons, West Sussex, UK2009
• Pulmonary Diseases and Disorders 
  Chapter: Cryptococcosis and the Endemic Mycoses. 
  Page 2327 - 2349*Wheat LJ. Goldman M, Knox, KEditors: Fishman, A.P..Edition Four,2008
• HIV InSite Knowledge Base [textbook on-line] 
  Chapter: Histoplasmosis and HIV Infection. 
  *Young E, Goldman MEditors: PeiperlL,Volberding PA.2005
• Management of the HIV infected Patient 
  Chapter: Candidiasis. 
  Page 469 - 477*Goldman M, Wheat JEditors: Crowe S, Hoy J, Mills J.Cambridge University Press, New York, NYEdition 2nd,2002
• Management of the HIV infected Patient 
  Chapter: Histoplasmosis, aspergillosis and miscellaneous mycoses and AIDS. 
  Page 479 - 495*Goldman M, Wheat JEditors: Crowe S, Hoy J, Mills J.Cambridge University Press, New York, NYEdition 2nd,2002
• Clinical Approach to Infection in the Compromised Host 
  Chapter: Fungal infections in the compromised host. 
  Page 215 - 247*Wheat LJ, Goldman M, Sarosi GEditors: Rubin RH, Young LS.Kluwer Academic/Plenum Publishers, New York, NYEdition 4th,2002
• Advances in Medicine 
  Chapter: Infectious mononucleosis. 
  Page 38 - 43*Vail GM, Goldman MEditors: Edlich, RF.ABI Professional Publications, Arlington, VA2000
• Current Therapy of Infectious Disease 
  Chapter: Histoplasmosis. 
  Page 713 - 715*Goldman M,SarosiGAEditors: Schlossberg D.Harcourt, Orlando, FLEdition 2nd,2000
• Conn’s Current Therapy 
  Chapter: Infectious Mononucleosis. 
  Page 120 - 122*Goldman MEditors: Rakel R.W.B. Saunders Company, Philadelphia, PA1997
• Manual of HIV Therapeutics 
  Chapter: Management of Mycoses AIDS. 
  Page 187 - 192*Wheat LJ, Goldman MEditors: Powderly WG.Lippincott-Raven Publishers, Philadelphia, PA1997
• Pulmonary Diseases and Disorders 
  Chapter: Cryptococcal infections. 
  Page 2306 - 2312*Goldman M, Wheat LJEditors: Fishman, A.P..McGraw-HillEdition Thir,1997
• Issues in Mycology 
  Chapter: Candidiasis in immunocompromised patients: treatment and prevention. 
  Page 1 - 20* Goldman M, Wheat LJEditors: Wingard WR.Cligott Communications, Greenwich, CN1997
• Specialty Review in Infectious Diseases Volume 1 
  Chapter: Infections in the compromised host (neutropenic patients and bone marrow transplant recipients). 
  Goldman MThe National Center for Advanced Medical Education, Chicago, IL1996
• Conn’s Current Therapy 
  Chapter: Histoplasmosis. 
  Page 190 - 194Goldman M, Wheat LJEditors: Rakel R.W.B. Saunders Company, Philadelphia, PA1996
• Contemporary Mycoses of Clinical Significance 
  Chapter: The endemic mycoses: coccidiodomycosis, histoplasmosis and blastomycosis. A continuing education videotape. 
  Goldman MMedical Mycological Society of the Americas/ Gardiner-Caldwell Synermed1995
• Specialty Review in Infectious Diseases Volume 1 
  Chapter: Infections in the compromised host (Neutropenic and transplant recipient) 
  Goldman MThe National Center for Advanced Medical Education, Chicago, IL1994
• Quick Reference to Internal Medicine 
  Chapter: Infective endocarditis. 
  Page 507 - 512Goldman M, Weaver DC, Levin SEditors: Bone RC, Rosen RL.IgakuShoin Medical Publishers, New York, NY1994
• Join now to see all

Abstracts/Posters

• Invited Presentation: Indiana University IM Residency Peer Professionalism Committee as a Method to Provide Education: Meeting of the Education Innovation Program of t...
  Goldman M, Fall Meeting of the Association of Program Directors in Internal Medicine (APDIM), Washington, DC, 1/11/2014
• PBLiPads: Utilization of Hand-Held Technology in Residency Education.
  Djuricich AM, Mehta R, Goldman M, Association of Program Directors in Internal Medicine (APDIM) Workshop2012 APDIM Spring Meeting “Milestones on the Road to Safety”, Atlanta, GA, 1/24/2012
• Beyond Procedures: Expanding the Role of Simulation in Medical Resident Training.
  Jackson, Mollie DO, Mehta, Rakesh MD, Clary, Kevin, MD, Djuricich, Alex MD, Hedrick, David MD, Ramig, Nicole MD, Chuu, Kenny MD, Goldman, Mitch MD, Abstracts of the Association of Program Directors in Internal Medicine (APDIM) 2011 Spring Meeting, Caesar's Palace, Las Vegas, NV, 1/12/2011
• Investigation of a cluster of Idiopathic Granulomatous Mastitis in Hispanic women - Indiana, 2009.
  Meites E; Jarquin VG; Ritchey M; Sanchez C; Selke HM; Goldman M; Pardo I;. Clare SE; Emerson R; Chester T;.Sinkowitz-Cochran RL; Shieh W; Zaki S; Howell JF; Srinivasan..., Abstracts of the Council of State and Territorial Epidemiologists Annual Conference, Portland, OR, 1/6/2010
• The relationships between renal dysfunction and clinical outcomes in HIV-infected Kenyans not requiring immediate ART.
  Wools-Kaloustian K, Owino-On g’or W, Wafula S, Shen C, Musick B, Goldman M, Gupta S, Abstracts of the 16th Conference on Retroviruses and Opportunistic Infections, Montreal, Canada, 1/8/2009
• The third generation smallpox vaccine IMVAMUNE® in HIV-infected subjects: complete data set of a phase 2 clinical trial.
  Greenberg RN, Overton TE, Haas DW , Frank I, Goldman M, Von Krempelhuber A, Vollmar J, Virgin G, Chaplin P, Abstracts of the 48th Annual ICAAC / 46th Annual IDSA Meeting, Washington, DC, 1/25/2008
• Safety and immunogenicity of MVA-BN (IMVAMUNE) smallpox vaccine in HIV infected subjects.
  Greenberg RN, Overton T, Haas D+, Frank I, Goldman M, Von Krempelhuber A, Chaplin P, Virgin G,Wulff N, Baedeker N, Vollmar J, 5th Annual ASM Biodefense and Emerging Diseases Research Meeting, Washington, DC, 1/27/2007
• Renal disease in an antiretroviral naive HIV-infected population in western Kenya Abstract #:MoPe11.6C23.
  Muloma E, Owino-Ong’or W, Sidle J. Gupta S, Aubrey R, Kipruto K, Goldman M, Wools-Kaloustian K, Abstracts of the 3rd IAS Conference on HIV Pathogenesis and Treatment, Rio de Janeiro, Brazil, 1/24/2005
• Activity of newer triazoles against fluconazole-resistant Histoplasmacapsulatum isolates. Abstract #M-1637
  Wheat LJ, Connolly PA, Smedema ML, Durkin MM, Goldman M, Abstracts of the 45th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, DC, 1/16/2005
• Sex-Based Differences in the Pharmacokinetics of Intravenous Levofloxacin.
  Overholser BR, Kays MB, Lagvankar S, Goldman, M., Sowinski KM, Abstracts of the 105th Meeting of the American Society for Clinical Pharmacology and Therapeutics; ClinPharmacolTher, Miami, FL, 1/24/2004
• Posaconazole (POS) salvage therapy for invasive fungal infections (IFI).Abstract# M-669.
  Raad I, Chapman S, Bradsher, R, Morrison V, Goldman M,Graybill J, Perfect JR, Patterson T, Walsh T, Corcoran G, Pappas P, Abstracts of the 44th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, DC, 1/1/2004
• “Discontinuation of Antifungal Therapy for Disseminated Histoplasmosis (DH) following Immunologic Response to Antiretroviral Therapy (ART) is Safe : AIDS Clinical Tria...
  Goldman M, 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL, 1/16/2003
• “Discontinuation of Antifungal Therapy for Disseminated Histoplasmosis following Immunologic Response to Antiretroviral Therapy (ART) is Safe : AIDS Clinical Trials G...
  Goldman M, NIH/AIDS Clinical Trials Group Meeting, Washington, DC, 1/1/2003
• Effect of Ensure on the Oral Bioavailability of Gatifloxacin in Healthy Volunteers.
  Kays MB, 1Overholser BR, Lagvankar S, Goldman M, Sowinski KM, Abstract# A-1626 in: Abstracts of the43rd Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL, 1/1/2003
• Discontinuation of Antifungal Therapy for Disseminated Histoplasmosis (DH) following Immunologic Response to Antiretroviral Therapy (ART) is Safe : AIDS Clinical Trial...
  Goldman M, Zackin R, Fichtenbaum CJ, Wheat LJ, Koletar SL, SkiestDJ,Schnizlein-Bick CT, Hafner R, Nyangweso P, Yiannoutsos C, Andersen JW, Owens S, Hogg E, Aberg JA.; ..., Late Breaker supplement to Abstracts of the43rd Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL, 1/1/2003
• Randomized Study of Long-Term Chronic Suppressive Fluconazole vs. Episodic Fluconazole for Patients with Advanced HIV Infection and History of Oropharyngeal Candidiasi...
  Goldman M, International Meeting Clinical Mycology Session, ICAAC Meeting, San Diego, CA, 1/29/2002
• Resistance to Tipranavir is Uncommon in a Randomized Trial of Tipranavir/Ritonavir (TPV/RTV) in Multiple PI-Failure Patients (BI 1182.2) Abstract# G1026e.
  *R. Schwartz, P. Kazanjian, L. Slater, B. Hathaway, M. Markowitz, D. Wheeler, *M. Goldman ,M. Drulak, S. McCallister, and D. Mayers, Abstracts of the 9th Conference on Retroviruses and Opportunistic Infections, Seattle, WA, 1/1/2002
• Randomized study of long-term chronic suppressive fluconazole (FLU) vs. episodic FLU for patients with advanced HIV infection and history of oropharyngeal candidiasis ...
  Goldman M, Filler SG,. Cloud GA and the ACTG 323 MSG 40 Study Group, Abstracts of the 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA, 1/1/2002
• Clearance of Fungal Burden During Treatment of Disseminated Histoplasmosis with Liposomal Amphotericin B (Ambisome) vs. Itraconazole in Patients with AIDS. Abstract# L...
  Wheat LJ, Cloud G, Johnson P, Connoly P, Goldman M, Le Monte A, Fuller D, Davis T, Hafner R, Abstracts of the 8th Conference on Retroviruses and Opportunistic Infections, Chicago, IL, 1/1/2001
• Long-term antifungal prophylaxis in allogeneic bone marrow transplant patients: a multicenter, randomized trial of intravenous/oral itraconazole versus intravenous/ora...
  Winston DJ, Maziarz RT,.Chandrasekar PH,. Lazarus HM, *Goldman M, Leitz G, Territo MC, Abstracts of the Annual Meeting of the American Society of Hematology, Orlando, FL, 1/1/2001
• A Multicenter Randomized Trial Comparing Amphotericin B as Induction Therapy of Disseminated Histoplasmosis in AIDS Patients.
  Johnson P, Wheat L, Cloud G, Powderly W, Lancaster D, Bamberger D, *Goldman M, Hafner R, Dismukes W and the NIAID Mycoses Study Group, Abstracts of the 7th Conference on Retroviruses and Opportunistic Infections, San Francisco, CA, 1/1/2000
• Infectious disease prophylaxis in renal transplant patients: A survey of US transplant centers.
  Batiuk TD, Goldman M, Bodziak K, Transplantation, 1/1/2000
• Diagnosis of Pneumocystis Carinii Pneumonia (PCP) in HIV-Infected Persons using PCR Testing on BAL Fluid: A Blinded Comparison to Standard Methods.
  Torres J, *Goldman M Lee CH, Bartlett MS, Tang X, Smith JW, Allen SD, Connolly PA, Wheat J, Abstracts of the 5th Conference on Retroviruses and Opportunistic Infections, Chicago, IL, 1/1/1998
• Typing of Sequential Candida albicans Isolates by Random Amplification of Polymorphic DNA (RAPD).
  Lemonte AM, Smedema ML, Connolly PA, *Goldman M, McKinsey DS, Wheat LJ, Abstracts of the 5th Conference on Retroviruses and Opportunistic Infections, Chicago, IL, 1/1/1998
• Screening for Hyperglycemia and Hyperlipidemia in HIV-Infected Persons Receiving Protease Inhibitors. [Abstract #I-072]
  *Vail M, *Goldman M, Frank M, Cushing H, Wheat J, Deeg M, Gibson R, Abstracts of the 38thInterscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA, 1/1/1998
• Join now to see all

Lectures

• Milestones and the New Accreditation System for IM Fellowships. 
  1/24/2014
• Entrustable Professional Activities (EPAs) and Building a Milestone-Based Evaluation System: Hands on examples 
  1/23/2014
• Central Nervous System Infections 
  Indianapolis, IN - 1/17/2014
• Lecture: Entrustable Professional Activites in the Next Acreditation System 
  1/13/2014
• “Ethical Issues in HIV/AIDS” 
  Indianapolis, IN - 1/13/2014
• Indiana University IM Residency Peer Professionalism Committee as a Method to Provide Education: Meeting of the Education Innovation Program of the ACGME 
  Washington, DC - 1/11/2014
• Introduction to Clinical HIV/AIDS. 
  Indianapolis, IN - 1/1/2014
• HIV/AIDS 
  Indiana University - 1/18/2013
• Clinicopathologic Conference 
  Indiana Universoty Medical Center, Indianapolis, IN - 1/15/2013
• Infectious Diseases Board Review 
  Roudebsuch Veteran’s Hospital, Indianapolis, IN - 1/9/2013
• “Stump the chumps” 
  Indianapolis, IN - 1/15/2012
• Use of Vaccines in Adults 
  Indianapolis, IN - 1/15/2012
• Serious Gram Positive Infections. 
  1/12/2012
• Presentation: “Stump the chumps” 
  Indianapolis, IN, Oct 30, 2010 - 1/28/2011
• Serious Community Acquired Infections 
  Indianapolis, IN - 1/26/2011
• HIV in the Elderly 
  Wishard Hospital, Indianapolis, IN - 1/14/2011
• Clostridium difficile Nastier than Ever 
  Tucson, AZ - 1/31/2010
• Serious Gram positive infections 
  Tucson, AZ - 1/24/2010
• “Infections in Patients following Hematopoietic Stem Cell Transplant” 
  Tucson, AZ - 1/11/2010
• “HIV Post-Exposure Prophylaxis for Healthcare Personnel” 
  1/4/2010
• “Infections in Patients with Hematologic Malignancies and following Hematopoietic Stem Cell Transplant” 
  Ohio State University, Columbus, OH - 1/24/2009
• Update in the Management of HIV Infection 
  Indianapolis, IN - 1/23/2009
• "Ethical Issues in HIV/AIDS” 
  Indianapolis, IN - 1/20/2009
• Superschool: Nosocomial Infections 
  Indianapolis, IN - 1/12/2009
• Update on HIV Infection 
  Tucson, AZ - 1/9/2009
• Join now to see all

Other

• Using mobile tablets in medical education. 
  Djuricich AM, *Goldman M, Academic Internal Medicine Insight
  1/1/2013
• Idiopathic granulomatous mastitis cases in hispanic women – Indiana, 2006-2008. 
  * Goldman M,Selke HM, Pardo I, Clare SE, Emerson RE, Howell JF, Shieh W-J, Zaki S, Sanchez C, Sinkowitz-Cochran RL, Srinivasan A , Jhung M, Ritchey M, Jarquin VG, Meit..., Morbidity and Mortality Weekly Report
  1/4/2009
• Can MAC and PCP prophylaxis be stopped? 
  Goldman M, AIDS Clinical Trials (local publication)
  1/1/1998
• “Threat of Superbugs” (bacteria that are resistant to antibiotics)” Discussion focused on what residents of Indiana should do to decrease the incidence of such infect... 
  Goldman M, Local ABC News
  1/3/1997
• News Interview: Regarding New Therapies for HIV Infection 
  Goldman M, Channel 8
  Indianapolis, IN - 1/1/1995
• Join now to see all